Oversold

BCRX

Same as last week
Valuation50/ 100
Cash flow & growth50/ 100
Upside potential45/ 100
Risk potential38/ 100

BCRX's valuation appears fair, fundamentals are somewhat mixed and the outlook sends mixed signals, though analyst coverage is limited and estimates vary widely.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +68.7%, operating margin -43 percentage points. The business score is 50/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Weaker business results limit upside support. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 31.6% upside, or about $10.69.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure; the separate operating stress is 36.4%. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 38.2% downside, or about $5.02, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

BCRX vs Historical averages

MetricCurrentAverageRelative
EPS-$1.50-$0.87$0.63 lower
FCF$357.1M-$70.5M+$427.6M
Loading historical comparisons…

BCRX’s earnings are below their historical averages.

BCRX Forward outlook

MetricOutlook
Forward valuation--
Forward earningsTurning positive
Forward revenueStrong decline
Forward profitabilityStrongly expanding
Analyst coverageLimited
Estimate dispersionWide

BCRX’s outlook is mixed, with declining sales expectations a concern.

BCRX PE Valuation

Loading pe valuation table…

This table applies BCRX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

BCRX Earnings Per Share

Loading earnings per share…

This chart tracks BCRX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

BCRX Quarterly Revenue

Loading quarterly revenue…

This chart tracks BCRX's quarterly revenue over time and shows how sales are changing from year to year.

BCRX Free Cash Flow

Loading free cash flow…

This chart tracks BCRX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

BCRX Total Shares

Loading shares over time…

This chart tracks changes in BCRX's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

BCRX Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

BCRX PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares BCRX's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

BCRX Weekly Price

Loading weekly price…

This chart uses BCRX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

BCRX Weekly Moving Averages

Loading weekly moving averages…

This chart compares BCRX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

BCRX Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

UNH

Same as last week
Valuation47/ 100
Cash flow & growth46/ 100
Upside potential49/ 100
Risk potential31/ 100

UNH's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins.

Valuation

Historical cheapness: current PE is 24.4× versus the full-history median of 21.5× shown in the valuation table, producing 41.5/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 46.9/100. The model applies a 21.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 22.4× (18-month half-life). The favorable scenario uses 24.6× PE and $20.4 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +6.5%, earnings -32.6%, operating margin -2.5 percentage points. Free cash flow is 5.2% of revenue. The business score is 45.6/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $20.39 of EPS and a 24.6× PE, suggesting a share price of about $500.50. Valuation history and outlook inform the PE.

The displayed favorable scenario is 32% upside, or about $500.40.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $13.45 of EPS and a 19.6× PE, suggesting a share price of about $262.95 — 31% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

UNH vs Historical averages

MetricCurrentAverageRelative
PE24x23x8% higher
PE percentile715042% higher
EPS$15.55$18.6717% lower
FCF$23.6B$21.7B9% higher
Loading historical comparisons…

UNH’s fundamentals are mixed relative to their historical averages, while its earnings multiple is higher.

UNH Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueStable
Forward profitabilityExpanding
Analyst coverageModerate
Estimate dispersionModerate

UNH’s outlook is generally improving, with growth expectations supporting the valuation case.

UNH PE Valuation

Loading pe valuation table…

This table applies UNH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

UNH Earnings Per Share

Loading earnings per share…

This chart tracks UNH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

UNH Quarterly Revenue

Loading quarterly revenue…

This chart tracks UNH's quarterly revenue over time and shows how sales are changing from year to year.

UNH Free Cash Flow

Loading free cash flow…

This chart tracks UNH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

UNH Total Shares

Loading shares over time…

This chart tracks changes in UNH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

UNH Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

UNH PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares UNH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

UNH Weekly Price

Loading weekly price…

This chart uses UNH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

UNH Weekly Moving Averages

Loading weekly moving averages…

This chart compares UNH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

UNH Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.